Valeant's Discussions to Sell Salix to Takeda Have Broken Down

Valeant ’s talks to sell a stomach-drug business to Japan’s Takeda Pharmaceutical for roughly $10 billion have broken down.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Pharmaceuticals